153 related articles for article (PubMed ID: 23072840)
21. Relationships between immunophenotype, Ki-67 index, microvascular density, Ep-CAM/P-cadherin, and MMP-2 expression in early-stage invasive ductal breast cancer.
Niemiec JA; Adamczyk A; Małecki K; Majchrzyk K; Ryś J
Appl Immunohistochem Mol Morphol; 2012 Dec; 20(6):550-60. PubMed ID: 22531681
[TBL] [Abstract][Full Text] [Related]
22. Expression of cell adhesion molecules and prognosis in breast cancer.
Saadatmand S; de Kruijf EM; Sajet A; Dekker-Ensink NG; van Nes JG; Putter H; Smit VT; van de Velde CJ; Liefers GJ; Kuppen PJ
Br J Surg; 2013 Jan; 100(2):252-60. PubMed ID: 23175431
[TBL] [Abstract][Full Text] [Related]
23. Nuclear and cytoplasmic accumulation of Ep-ICD is frequently detected in human epithelial cancers.
Ralhan R; He HC; So AK; Tripathi SC; Kumar M; Hasan MR; Kaur J; Kashat L; MacMillan C; Chauhan SS; Freeman JL; Walfish PG
PLoS One; 2010 Nov; 5(11):e14130. PubMed ID: 21152431
[TBL] [Abstract][Full Text] [Related]
24. Predictive value of E-cadherin and Ep-CAM in cervical lymph node metastasis of supraglottic larynx carcinoma.
Ali Bayram ; Yüce İ; Çağlı S; Canöz Ö; Güney E
Am J Otolaryngol; 2015; 36(6):736-40. PubMed ID: 26545462
[TBL] [Abstract][Full Text] [Related]
25. Subcellular differential expression of Ep-ICD in oral dysplasia and cancer is associated with disease progression and prognosis.
Somasundaram RT; Kaur J; Leong I; MacMillan C; Witterick IJ; Walfish PG; Ralhan R
BMC Cancer; 2016 Jul; 16():486. PubMed ID: 27421772
[TBL] [Abstract][Full Text] [Related]
26. Loss of membranous Ep-CAM in budding colorectal carcinoma cells.
Gosens MJ; van Kempen LC; van de Velde CJ; van Krieken JH; Nagtegaal ID
Mod Pathol; 2007 Feb; 20(2):221-32. PubMed ID: 17361206
[TBL] [Abstract][Full Text] [Related]
27. Expression of Ep-CAM in intestinal metaplasia, gastric epithelial dysplasia and gastric adenocarcinoma.
Joo M; Kim H; Kim MK; Yu HJ; Kim JP
J Gastroenterol Hepatol; 2005 Jul; 20(7):1039-45. PubMed ID: 15955212
[TBL] [Abstract][Full Text] [Related]
28. Cytoplasmic tail regulates the intercellular adhesion function of the epithelial cell adhesion molecule.
Balzar M; Bakker HA; Briaire-de-Bruijn IH; Fleuren GJ; Warnaar SO; Litvinov SV
Mol Cell Biol; 1998 Aug; 18(8):4833-43. PubMed ID: 9671492
[TBL] [Abstract][Full Text] [Related]
29. Correlation of COX-2 and Ep-CAM overexpression in human invasive breast cancer and its impact on survival.
Spizzo G; Gastl G; Wolf D; Gunsilius E; Steurer M; Fong D; Amberger A; Margreiter R; Obrist P
Br J Cancer; 2003 Feb; 88(4):574-8. PubMed ID: 12592372
[TBL] [Abstract][Full Text] [Related]
30. Epithelial cell adhesion molecule expression in pituitary adenomas: an immunohistochemical study.
Ortiz-Plata A; Moreno-Leyva K; López-Gómez M; Santos-Salinas S; Sánchez-García A; Tena-Suck ML
Ann Diagn Pathol; 2010 Dec; 14(6):418-24. PubMed ID: 21074690
[TBL] [Abstract][Full Text] [Related]
31. Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue.
Hein S; Müller V; Köhler N; Wikman H; Krenkel S; Streichert T; Schweizer M; Riethdorf S; Assmann V; Ihnen M; Beck K; Issa R; Jänicke F; Pantel K; Milde-Langosch K
Breast Cancer Res Treat; 2011 Sep; 129(2):347-60. PubMed ID: 20972617
[TBL] [Abstract][Full Text] [Related]
32. EpCAM nuclear localization identifies aggressive thyroid cancer and is a marker for poor prognosis.
Ralhan R; Cao J; Lim T; Macmillan C; Freeman JL; Walfish PG
BMC Cancer; 2010 Jun; 10():331. PubMed ID: 20579375
[TBL] [Abstract][Full Text] [Related]
33. A shift from membranous and stromal syndecan-1 (CD138) expression to cytoplasmic CD138 expression is associated with poor prognosis in breast cancer.
Kind S; Jaretzke A; Büscheck F; Möller K; Dum D; Höflmayer D; Hinsch A; Weidemann S; Fraune C; Möller-Koop C; Hube-Magg C; Simon R; Wilczak W; Lebok P; Witzel I; Müller V; Schmalfeldt B; Paluchowski P; Wilke C; Heilenkötter U; von Leffern I; Krech T; Krech RH; von der Assen A; Bawahab AA; Burandt E
Mol Carcinog; 2019 Dec; 58(12):2306-2315. PubMed ID: 31545001
[TBL] [Abstract][Full Text] [Related]
34. [Expressions of Ep-CAM and cyclin D1 and their clinical significance in gallbladder carcinoma].
Ren G; Yu G; Liu LW; Ma L
Zhonghua Zhong Liu Za Zhi; 2009 Nov; 31(11):841-4. PubMed ID: 20137349
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of nuclear hepatoma-derived growth factor (HDGF) localization in patients with breast cancer.
Chen X; Yun J; Fei F; Yi J; Tian R; Li S; Gan X
Pathol Res Pract; 2012 Aug; 208(8):437-43. PubMed ID: 22682760
[TBL] [Abstract][Full Text] [Related]
36. Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers.
Went P; Vasei M; Bubendorf L; Terracciano L; Tornillo L; Riede U; Kononen J; Simon R; Sauter G; Baeuerle PA
Br J Cancer; 2006 Jan; 94(1):128-35. PubMed ID: 16404366
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of S100A4-expression and subcellular localization in early-stage breast cancer.
Egeland EV; Boye K; Park D; Synnestvedt M; Sauer T; ; Naume B; Borgen E; Mælandsmo GM
Breast Cancer Res Treat; 2017 Feb; 162(1):127-137. PubMed ID: 28058579
[TBL] [Abstract][Full Text] [Related]
38. Fatty acid binding protein 7 expression and its sub-cellular localization in breast cancer.
Alshareeda AT; Rakha EA; Nolan CC; Ellis IO; Green AR
Breast Cancer Res Treat; 2012 Jul; 134(2):519-29. PubMed ID: 22562177
[TBL] [Abstract][Full Text] [Related]
39. Specific targeting of Ep-CAM in various carcinomas by novel monoclonal antibodies.
Sithambaram D; Palanivelu S; Subramanian K; Sahoo S; Verma RS
Hybridoma (Larchmt); 2011 Dec; 30(6):511-8. PubMed ID: 22149275
[TBL] [Abstract][Full Text] [Related]
40. Expression of MUC 1 and Ep-CAM in Merkel cell carcinomas: implications for immunotherapy.
Kurzen H; Kaul S; Egner U; Deichmann M; Hartschuh W
Arch Dermatol Res; 2003 Aug; 295(4):146-54. PubMed ID: 12844224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
